MZMurat Zeytunlu

Murat Zeytunlu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Murat Zeytunlu has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and Internal Validation of the MELD–ERT Score for Mortality Risk Stratification After Liver Transplantation

    by Bartu Çetin, Murat Zeytunlu

    Background/Objectives: The Model for End-Stage Liver Disease (MELD) score reflects pretransplant disease severity, but does not capture intraoperative factors that may influence post-transplant outcomes. This study aimed to develop and internally validate a composite MELD–erythrocyte transfusion (ERT) score for mortality risk stratification after liver transplantation (LT). Methods: This retrospective, single-center cohort study included 125 adult LT recipients between August 2024 and July 2026. A MELD–ERT score (0–2) was constructed using ROC-derived cut-offs for MELD and intraoperative ERT. Prognostic performance for mortality and overall survival (OS) was evaluated using regression, conventional and time-dependent ROC and survival analyses, with bootstrap internal validation. Results: During a median follow-up of 544 days, 30 patients (24.0%) died. MELD and ERT were independently associated with mortality. Mortality increased stepwise across MELD–ERT scores of 0, 1, and 2 (0%, 36.2%, and 59.1%, respectively). The MELD–ERT score showed good discrimination (AUC 0.836, 95% CI 0.776–0.897), with an optimism-corrected AUC of 0.818 after bootstrap validation. Its discrimination was comparable to MELD alone (p = 0.660) and superior to ERT alone (p = 0.002). Time-dependent AUCs for MELD–ERT were 0.893, 0.930, 0.837, and 0.812 at 3, 6, 12, and 24 months, respectively. OS differed significantly across score categories (log-rank p < 0.001), and high-risk patients had a 9.7-month shorter 24-month RMST (95% CI 5.4–14.3; p < 0.001). Conclusions: The MELD–ERT score provides a simple approach to post-LT mortality risk stratification and demonstrated good discrimination after internal validation. However, it did not significantly outperform MELD alone. External validation is warranted.

  • Open Access

    Biliary Duct Invasion in Colorectal Liver Metastases: Prevalence and Clinicopathologic Correlation in a Retrospective Cohort Study

    by Fatma Yildirim, Asuman Argon, Alper Uguz, Murat Sezak, Basak Doganavsargil, Murat Zeytunlu, Deniz Nart, Funda Yilmaz

    Biliary duct invasion (BDI) is an underrecognized growth pattern of colorectal cancer (CRC) liver metastases that can mimic intrahepatic cholangiocarcinoma or intraductal papillary neoplasm of the bile duct. Its prevalence and clinicopathologic associations remain unclear. This study aimed to determine the prevalence of BDI and its clinicopathologic associations in surgically resected CRC liver metastases.

  • Evaluation of Donor Exclusions for Living Donor Liver Transplantation in a Tertiary Center

    by Tufan Gumus, Veysel Umman, Berk Sertoz, Ezgi Guler, Alper Uguz, Ozen Onen Sertoz, Elvan Isik, Fulya Gunsar, Murat Zeytunlu, Sukru Emre


  • Open Access

    Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye

    by İlKer Turan, Ulus Salih Akarca, Murat Aladağ, Murat Harputluoğlu, Sezai Yılmaz, Genco Gençdal, Çiğdem Arıkan, Kamil Yalçın Polat, Figen Özçay, Mesut Akarsu, et al.

    This multicenter retrospective study analyzed 336 patients (236 adults, 100 children) who underwent liver transplantation (LT) for acute liver failure (ALF) between 2002 and 2019 across 14 centers in Türkiye. The aim was to evaluate pretransplant factors influencing short-term posttransplant survival. Median MELD and PELD scores were 31 and 30, respectively. The most common ALF etiologies were viral, indeterminate, and drug-induced causes. Living donor liver transplantation (LDLT) was more common in children (86.0%) than adults (57.2%). Mean posttransplant survival was 166±9 months in children and 117±6 months in adults. In adults, LDLT significantly improved survival compared to deceased donor LT (DDLT), with survival of 135 vs. 89 months (p=0.0012). Although pediatric LDLT recipients had longer mean survival than DDLT recipients (167 vs. 132 months), this difference was not statistically significant (p=0.5959). Three-month mortality was associated with low albumin and grade 4 hepatic encephalopathy (HE) in children. In adults, independent predictors of early mortality included DDLT, serum sodium >140 mEq/L, MELD >35, pH <7.3, and grade 4 HE. Our data suggest that LDLT may offer a survival advantage, particularly in adults with ALF. Identifying pretransplant risk factors is essential for improving early outcomes and guiding clinical decision-making.


  • Open Access

    Metabolic and surgical factors affecting postoperative quality of life in patients with total pancreatectomy with or without splenectomy: Single center results

    by Veysel Umman, Tufan Gümüş, Ebubekir Korucuk, Recep Temel, Fırat Başçı, Alper Uguz, Murat Zeytunlu

    Objective: Pancreatic resection may be required in the treatment of patients with pathologies of the pancreas. Total pancreatectomy is a major surgical procedure with serious risk of mortality and morbidity, and patient selection is important for prognosis. The endocrine and exocrine pancreatic insufficiency that develops in patients after total pancreatectomy can lead to a serious decrease in the quality of life of the patients due to pain, diarrhea, vomiting etc. Our aim was to evaluate the effect of total pancreatectomy with spleen preservation as well as splenectomy on the quality of life of the patients. Material and Methods: In our study, we retrospectively analyzed the data of patients diagnosed with pancreatic cancer, intrapapillary mucinous neoplasia, pancreatic neuroendocrine tumors, and chronic pancreatitis undergoing from partial to total pancreatic resections in our clinic between 12/2017 and 12/2022. Quality of life was compared using the EORTC QLQ-C30 scale. Results: A total of 47 total pancreatectomy patients, 30 (63.8%) males and 17 (36.2%) females, were included in the study. Mean age of the patients was 61.38 (39-83) years. Five (35.7%) patients underwent perioperative total pancreatectomy because of high risk of pancreatic fistula development due to hard parenchyma and narrow pancreatic duct. Patients had a perioperative blood loss of 500 mL or more, and there was a statistically significant increase in perioperative blood loss compared to patients without vascular resection (p< 0.001). Forty (85.1%) patients used enzyme preparations to replace pancreatic enzymes. Conclusion: After total pancreatectomy, quality of life of the patients is reduced both by surgical factors and by metabolic factors due to endocrine and exocrine insufficiency in the postoperative period.


  • Open Access

    A new method for predicting alcohol relapse in patients undergoing liver transplantation for alcohol-related liver failure: Barratt scale

    by Veysel Umman, Ebubekir Korucuk, Recep Temel, Ozen Onen Sertoz, Fulya Gunsar, Alper Uguz, Murat Zeytunlu, Sukru Emre

    Background and Aim: Alcohol-induced liver disease has become one of the major causes of chronic liver disease worldwide with the increasing use of alcohol in society. The most important step in treatment is cessation of alcohol consumption. In patients with advanced liver disease, the most effective treat-ment is liver transplantation. Careful evaluation of patients with alcoholic liver disease before transplantation can help identify those at high risk of relapsing. Materials and Methods: Of a total of 42 patients who underwent liver trans-plantation for alcohol-related liver failure in our hospital between 2011 and 2022, 26 surviving patients were included in the study. Patient data were analyzed ret-rospectively. Demographic data, MELD score, history of alcohol consumption, alcohol treatment, post-transplant prognosis and survival were analyzed. The Barratt Impulsivity Scale-11 Short Form (BIS-11 SF) was applied to the surviv-ing patients for impulsivity analysis to predict the possibility of relapse. Results: Of the 26 patients who were included in the study, all were male. The mean age at transplantation was 53 (31–71) years. Mean MELD score was 22.31 (9–36). 12 patients (46.2%) received living donor liver transplan-tation and 14 patients (53.8%) received cadaveric liver transplantation. 25 patients (96.2%) had no post-transplant dependence, while 1 patient (3.8%) had post-transplant dependence. 5 patients (19.2%) continued to consume alcohol after transplantation. Conclusion: In our study, we observed that patients with high motor impul-sivity tendency according to BSI-11 SF had alcohol relapse. We believe that revising this scale with more detailed questions for alcohol-dependent liver patients and applying it to patients before transplantation will be effective in better selection for transplantation and guiding patients to appropriate therapy and thus preventing relapse after transplantation.


  • Canlı Karaciğer Donörlerinde Yaşam Kalitesinin Değerlendirilmesi

    by Gizem Bayam, Gülseren Pamuk, Hilal Aksoy, Murat Zeytunlu, Kurtuluş ÖNGEL

    Objective: In this study, it was aimed to examine the effect of transplantation on physical, mental and psychosocial health of donors by evaluating the quality of life of living liver donors after transplantation.Material and Methods: The study was conducted with three groups at Ege University Faculty of Medicine Organ Transplantation and Research Center. 43 living donors from 2017 and 43 living donors from 2007-2016 who underwent liver transplantation were randomly selected to participate in the study. Also 43 control subjects were selected randomly from the community. The study was conducted by a single interviewer between 01.02.2018 and 31.05.2018 by telephone or e-mail. The socio-demographic data questionnaire, Short Form-36 (SF-36) and Hospital Anxiety-Depression Scale (HADS) prepared by the researchers were applied to all participants.Results: The mean age of the participants was 38.04±9.84 years, and of these participants 48.1% (n=62) of them were female. When donors and control group were evaluated in terms of their quality of life, no significant difference was found between physical role, energy (vitality) and mental health subgroups.However, donors have a better quality of life in physical functioning, emotional aspect, social functioning, pain and general health subgroups. It was detected that the quality of life was not affected by age, gender, marital status, educational status, economic status, job loss, comorbidity or disturbance by presence of operational scar. Only sexual problems and the loss of the recipient’s life were observed to have a negative impact on the quality of life. There was no significant difference between the groups in terms of anxiety and depression (p<0.05).Conclusion: In our study, it was determined that donors’ quality of life was not adversely affected by transplantation procedure. But it was observed that post-transplant follow-ups had not been performed properly. In addition to independent units that monitor physical, mental, and psychosocial health of living donors who undergo major surgery without any medical need, awareness should be increased to follow the quality of life by family medicine discipline which adopts biopsychosocial approach.

  • Open Access

    Preliminary Report of the ministry of health working group on standardization of living donor liver transplantation in Turkiye

    by Veysel Umman, Murat Zeytunlu, Zeki Karasu, Bülent Aydınlı, Fatih Kacıroğlu, Yusuf Yavuz, Ahmet Tekin, Sukru H Emre

    Liver transplantation is successfully applied all over the world and in our country. Donation from deceased donors has not reached to the desirable level in Turkey similar to many middle and far east countries. Therefore, in our country, living donors have been frequently used for liver transplantation. Although Turkey is the leading country performing LDLT in Europe and one of the top three countries around the world, nation-wide standardization of LDLT protocols including donor and recipient evaluation and acceptance criteria, donor and recipient follow-up and reporting rules and routine periodic audits by ministry of health authorities have not been established. Therefore, we created a work group to conduct a study reviewing regulations of LDLT operation in Europe and US. Establishment and implementation of standardization of LDLT operation will serve improving the donor and recipient outcomes while preventing incomplete or incorrect practices. The guide prepared on this subject is presented in the appendix


  • Ten-year single center experience in hepatotoxicity due to mushroom poisoning

    by Ozan Sarikaya, Ilker Turan, Fulya Günsar, Aysenur Arslan, Nilay Daniş, Ferit Çelik, Galip Ersoz, Sezgin Ulukaya, Murat Zeytunlu, Omer Ozutemiz, et al.